Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
RDNT 
RadNet Inc (RDNT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: RDNT (3-star) is a REGULAR-BUY. BUY since 34 days. Profits (2.48%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
7 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Year Target Price $71.57
Year Target Price $71.57
| 5 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 147.07% | Avg. Invested days 73 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.29B USD | Price to earnings Ratio - | 1Y Target Price 71.57 |
Price to earnings Ratio - | 1Y Target Price 71.57 | ||
Volume (30-day avg) - | Beta 1.44 | 52 Weeks Range 45.00 - 93.65 | Updated Date 06/29/2025 |
52 Weeks Range 45.00 - 93.65 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.43 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -1.73% | Operating Margin (TTM) -3.73% |
Management Effectiveness
Return on Assets (TTM) 1.65% | Return on Equity (TTM) 0.33% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 5315952799 | Price to Sales(TTM) 2.29 |
Enterprise Value 5315952799 | Price to Sales(TTM) 2.29 | ||
Enterprise Value to Revenue 2.84 | Enterprise Value to EBITDA 18.3 | Shares Outstanding 75030096 | Shares Floating 67247976 |
Shares Outstanding 75030096 | Shares Floating 67247976 | ||
Percent Insiders 13.06 | Percent Institutions 93.81 |
Analyst Ratings
Rating 4.71 | Target Price 71.57 | Buy 2 | Strong Buy 5 |
Buy 2 | Strong Buy 5 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
RadNet Inc
Company Overview
History and Background
RadNet Inc. was founded in 1983. Initially focused on managing radiology practices, it evolved into a national leader in outpatient imaging services through organic growth and acquisitions.
Core Business Areas
- Outpatient Diagnostic Imaging: RadNet's primary business is owning and operating outpatient imaging centers. They provide a comprehensive range of diagnostic imaging services.
- Managed Services: RadNet also offers managed services to hospitals and other healthcare providers, including staffing, equipment, and billing services.
- Technology Solutions: RadNet develops and licenses radiology information systems (RIS) and other technology solutions for managing imaging operations.
Leadership and Structure
Dr. Howard Berger is the Chairman and CEO. The company has a standard corporate structure with executive leadership overseeing various functional areas.
Top Products and Market Share
Key Offerings
- MRI Scans: Magnetic Resonance Imaging (MRI) scans are a significant part of RadNet's revenue. They compete with hospital-based imaging and other outpatient imaging providers. Market data varies but the out-patient MRI market is fragmented. Competitors include other imaging center chains and hospital radiology departments.
- CT Scans: Computed Tomography (CT) scans are another core offering. Similar to MRI, competition comes from hospitals and other outpatient centers. Market share data is fragmented. Competitors include other imaging center chains and hospital radiology departments.
- PET/CT Scans: Positron Emission Tomography/Computed Tomography (PET/CT) scans are used for cancer diagnosis and staging. This represents a growing segment of RadNet's services. Competitors include other imaging center chains and hospital radiology departments.
Market Dynamics
Industry Overview
The diagnostic imaging industry is growing, driven by an aging population, technological advancements, and increasing demand for early disease detection. Consolidation is occurring within the industry.
Positioning
RadNet is one of the largest operators of outpatient imaging centers in the US. Its competitive advantages include its scale, geographic footprint, and technology platform.
Total Addressable Market (TAM)
The US medical imaging market is expected to reach hundreds of billions of dollars. RadNet is positioned to capture a significant share through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Large network of outpatient imaging centers
- Strong relationships with referring physicians
- Advanced technology platform
- Experienced management team
- Ability to negotiate favorable reimbursement rates
Weaknesses
- High debt levels
- Dependence on reimbursement rates
- Exposure to regulatory changes
- Competition from hospitals
- Capital intensive business
Opportunities
- Acquisitions of smaller imaging centers
- Expansion into new geographic markets
- Development of new imaging technologies
- Growth in demand for outpatient imaging services
- Increased focus on preventive care
Threats
- Decreases in reimbursement rates
- Increased competition
- Technological obsolescence
- Economic downturns
- Changes in healthcare regulations
Competitors and Market Share
Key Competitors
- CVS (CVS)
- UnitedHealth Group (UNH)
- HCA Healthcare (HCA)
Competitive Landscape
RadNet competes with other large imaging center chains, hospital-based imaging departments, and smaller independent imaging centers. They focus on outpatient diagnostic services and face reimbursement and regulation pressure.
Major Acquisitions
Diagnostic Health Corporation
- Year: 2017
- Acquisition Price (USD millions): 78.5
- Strategic Rationale: Expansion in Texas and increased market share.
Growth Trajectory and Initiatives
Historical Growth: RadNet has grown significantly through acquisitions and organic growth over the past decade.
Future Projections: Analyst estimates vary, but generally project continued revenue growth and improved profitability.
Recent Initiatives: Recent initiatives include expanding into new markets, investing in new technology, and strengthening relationships with referring physicians.
Summary
RadNet is a leading outpatient imaging provider, growing through acquisitions and organic expansion. The company faces challenges related to reimbursement rates and debt but is well-positioned to benefit from the increasing demand for diagnostic imaging. Key strengths include its large network and technology platform, but its high debt and dependence on reimbursement pose risks. RadNet must continue to manage its costs and expand its service offerings to maintain its competitive edge.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About RadNet Inc
Exchange NASDAQ | Headquaters Los Angeles, CA, United States | ||
IPO Launch date 1986-07-01 | Chairman, President & CEO Dr. Howard G. Berger M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 11000 | Website https://www.radnet.com |
Full time employees 11000 | Website https://www.radnet.com | ||
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.